https://it.marketscreener.com/quotazioni/azione/WEREWOLF-THERAPEUTICS-INC-122186740/attualita/Werewolf-Therapeutics-presenta-i-dati-preclinici-su-mWTX-330-una-molecola-surrogata-dell-Indukina-I-42282359/?utm_source=telegram&utm_medium=social&utm_campaign=share